CareDx insider plans sale of 7,000 common shares

CareDx, Inc. (CDNA) received a notice of proposed sale of common stock by insider Peter Maag under a planned transaction.

Rhea-AI Filing Summary

CareDx, Inc. (CDNA) received a notice of proposed sale of common stock by insider Peter Maag under a planned transaction. The filing lists up to 7,000 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of 333851.00 as of 08/11/2026. It also reports prior common stock sales by Maag over the past three months, including 75,653 shares on 08/04/2026 for 3576851.19 and additional sales on 08/05/2026, 08/07/2026, and 08/10/2026.

Key Figures

Proposed shares to be sold: 7000 shares Proposed sale value: 333851.00 Sale on 08/04/2026: 75653 shares for 3576851.19 +3 more

6 metrics

Proposed shares to be sold 7000 shares Common stock proposed for sale as of 08/11/2026

Proposed sale value 333851.00 Indicated value for 7,000 common shares as of 08/11/2026

Sale on 08/04/2026 75653 shares for 3576851.19 Common stock sold by Peter Maag on 08/04/2026

Sale on 08/05/2026 46963 shares for 2178945.34 Common stock sold by Peter Maag on 08/05/2026

Sale on 08/07/2026 27332 shares for 1252491.63 Common stock sold by Peter Maag on 08/07/2026

Sale on 08/10/2026 6902 shares for 328949.32 Common stock sold by Peter Maag on 08/10/2026

Key Terms

Restricted Stock, Executive Financial Services, Securities To Be Sold

3 terms

Restricted Stock financial

"Common | 02/01/2023 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 02/01/2023"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CDNA Form 144 filing by Peter Maag disclose?

The filing discloses a proposed sale of 7,000 common shares of CareDx, Inc. (CDNA) by insider Peter Maag through Morgan Stanley Smith Barney LLC Executive Financial Services, along with details of his recent common stock sales.

How many CDNA shares are proposed to be sold in this notice?

The notice covers a proposed sale of up to 7,000 shares of CDNA common stock. The filing lists an indicated value of 333851.00 for these shares as of 08/11/2026, via Morgan Stanley Smith Barney LLC Executive Financial Services.

What CDNA share sales has Peter Maag made in the past three months?

Peter Maag reported multiple CDNA common stock sales, including 75,653 shares on 08/04/2026 for 3576851.19, 46,963 shares on 08/05/2026 for 2178945.34, 27,332 shares on 08/07/2026, and 6,902 shares on 08/10/2026.

Through which broker will the proposed CDNA share sale be executed?

The proposed sale of 7,000 CDNA common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, according to the Form 144 disclosure.

What type of CDNA securities are referenced as underlying this Form 144?

The disclosure references CDNA Common stock and prior grants of Restricted Stock from the issuer dated 02/01/2023, 01/29/2023, 01/06/2023, and 12/31/2023, with corresponding share amounts listed for each grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 06:12 PM Accepted by SEC EDGAR 08/11/2026 - 06:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001613855
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAREDX, INC.
SEC File Number	001-36536
Address of Issuer	8000 Marina Boulevard, Brisbane CALIFORNIA 94005
Phone	415-287-2300
Name of Person for Whose Account the Securities are To Be Sold	PETER MAAG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7000	333851.00	51734223	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2023	Restricted Stock	Issuer			2616	02/01/2023	Not Applicable
Common	01/29/2023	Restricted Stock	Issuer			1731	01/29/2023	Not Applicable
Common	01/06/2023	Restricted Stock	Issuer			834	01/06/2023	Not Applicable
Common	12/31/2023	Restricted Stock	Issuer			1819	12/31/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/10/2026	6902	328949.32
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/07/2026	27332	1252491.63
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/05/2026	46963	2178945.34
PETER MAAG 8000 Marina Boulevard, Brisbane CA 94005	Common	08/04/2026	75653	3576851.19

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Maag
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)